Literature DB >> 11485347

Bromelain activates murine macrophages and natural killer cells in vitro.

C R Engwerda1, D Andrew, M Murphy, T L Mynott.   

Abstract

The innate immune response is critical for effective immunity against most pathogens. In this study, we show that bromelain, a mixture of cysteine proteases, can enhance IFN-gamma-mediated nitric oxide and TNFalpha production by macrophages. Bromelain's effect was independent of endotoxin receptor activation and was not caused by direct modulation of IFN-gamma receptors. Instead, bromelain either enhanced or acted synergistically with IFN-gamma receptor-mediated signals. These effects were seen in both RAW 264.7, a macrophage cell line, and primary macrophage populations. Bromelain also increased IL-2- and IL-12-mediated IFN-gamma production by NK cells. These results indicate a potential role for bromelain in the activation of inflammatory responses in situations where they may be deficient, such as may occur in immunocompromised individuals. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485347     DOI: 10.1006/cimm.2001.1793

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  Dose-dependent induction of IL-6 by plant-derived proteases in vitro.

Authors:  B Rose; C Herder; H Löffler; G Meierhoff; N C Schloot; M Walz; S Martin
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

3.  Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells.

Authors:  Tracey L Mynott; Ben Crossett; S Radhika Prathalingam
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 4.  The Protective Role of Nutraceuticals in Critically Ill Patients with Traumatic Brain Injury.

Authors:  Farshid Rahimibashar; Masoum Khosh Fetrat; Keivan Gohari-Moghadam; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.

Authors:  Carla A Guimarães-Ferreira; Elaine G Rodrigues; Renato A Mortara; Hamilton Cabral; Fabiana A Serrano; Ricardo Ribeiro-dos-Santos; Luiz R Travassos
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

6.  Bromelain treatment decreases neutrophil migration to sites of inflammation.

Authors:  David J Fitzhugh; Siqing Shan; Mark W Dewhirst; Laura P Hale
Journal:  Clin Immunol       Date:  2008-05-14       Impact factor: 3.969

7.  Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes.

Authors:  Sandeep Dave; Naval Jit Kaur; Ravikanth Nanduri; H Kitdorlang Dkhar; Ashwani Kumar; Pawan Gupta
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

8.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10

9.  Modulation of Lipopolysaccharide Stimulated Nuclear Factor kappa B Mediated iNOS/NO Production by Bromelain in Rat Primary Microglial Cells.

Authors:  Soraya Abbasi Habashi; Farzaneh Sabouni; Ali Moghimi; Saeed Ansari Majd
Journal:  Iran Biomed J       Date:  2015-10-13

10.  Anti-inflammatory properties of a proprietary bromelain extract (Bromeyal™) after in vitro simulated gastrointestinal digestion.

Authors:  Roberta Bottega; Ilaria Persico; Francesco De Seta; Federico Romano; Giovanni Di Lorenzo
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.